Schonfeld Strategic Advisors LLC Arcus Biosciences, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$14.6 Billion
Q2 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 232,794 shares of RCUS stock, worth $3.92 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

232,794

Previous 103,860 124.14%

Holding current value

$3.92 Million

Previous $1.96 Million 80.87%

% of portfolio

0.02%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$14.59 - $18.48 $1.88 Million - $2.38 Million	128,934 Added 124.14%	232,794 $3.55 Million
Q1 2024 May 15, 2024	SELL	$14.83 - $20.18 $1.88 Million - $2.56 Million	-126,960 Reduced 55.0%	103,860 $1.96 Million
Q4 2023 Feb 14, 2024	BUY	$13.43 - $19.63 $1.18 Million - $1.73 Million	87,920 Added 61.53%	230,820 $4.41 Million
Q3 2023 Nov 14, 2023	SELL	$17.62 - $23.54 $706,984 - $944,518	-40,124 Reduced 21.92%	142,900 $2.57 Million
Q2 2023 Aug 14, 2023	SELL	$16.97 - $22.03 $1.88 Million - $2.44 Million	-110,786 Reduced 37.71%	183,024 $3.72 Million
Q1 2023 May 15, 2023	BUY	$15.96 - $23.15 $2.23 Million - $3.23 Million	139,471 Added 90.37%	293,810 $5.36 Million
Q4 2022 Feb 14, 2023	BUY	$19.7 - $35.71 $467,106 - $846,719	23,711 Added 18.15%	154,339 $3.19 Million
Q3 2022 Nov 14, 2022	SELL	$23.23 - $30.07 $812,120 - $1.05 Million	-34,960 Reduced 21.11%	130,628 $3.42 Million
Q2 2022 Aug 15, 2022	BUY	$17.23 - $37.73 $2.85 Million - $6.25 Million	165,588 New	165,588 $4.2 Million
Q1 2022 May 16, 2022	SELL	$28.92 - $41.83 $720,108 - $1.04 Million	-24,900 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$31.38 - $48.47 $15,690 - $24,235	500 Added 2.05%	24,900 $1.01 Million
Q3 2021 Nov 16, 2021	BUY	$26.93 - $37.68 $657,092 - $919,392	24,400 New	24,400 $851,000
Q2 2021 Aug 16, 2021	SELL	$22.75 - $35.77 $1.15 Million - $1.81 Million	-50,701 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$26.16 - $41.39 $917,588 - $1.45 Million	35,076 Added 224.49%	50,701 $1.42 Million
Q4 2020 Feb 16, 2021	BUY	$17.0 - $32.36 $265,625 - $505,625	15,625 New	15,625 $406,000

Others Institutions Holding RCUS

# of Institutions

204

Shares Held

48.9M

Call Options Held

173K

Put Options Held

151K

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.22B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Arcus Biosciences, Inc. Transaction History